STOCK TITAN
  1. Home
  2. News
  3. SINT

Sintx Technologies, Inc. - SINT STOCK NEWS

Welcome to our dedicated page for Sintx Technologies news (Ticker: SINT), a resource for investors and traders seeking the latest updates and insights on Sintx Technologies stock.

SINTX Technologies, Inc. (NASDAQ: SINT) is a pioneering advanced ceramics company, renowned for its development and production of medical-grade silicon nitride. This innovative biomaterial is not only ideal for spinal fusion applications but also boasts a variety of medical uses due to its unique nanosurface texture. This texture promotes bone growth, offers excellent imaging capabilities, and demonstrates antibacterial properties.

Originally known for its research, development, and commercialization of silicon nitride-based medical devices, SINTX has expanded its horizons. Today, the company is involved in a wide array of biomedical, technical, and antipathogenic applications. SINTX's biomedical products are celebrated for their biocompatibility, bioactivity, and exceptional bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in patients across the United States, Europe, Brazil, and Taiwan.

SINTX Technologies operates the only FDA-registered and ISO 13485 certified silicon nitride medical device manufacturing facility in the world. Their robust sales and distribution network underpins their commitment to delivering innovative healthcare solutions that significantly enhance patient quality of life.

In addition to medical devices, SINTX is actively engaged in developing solutions for various technical and antipathogenic applications. These efforts include the creation of advanced ceramic materials designed to meet the evolving needs of multiple industries.

  • Core Business: Manufacturing of medical-grade silicon nitride and advanced ceramics for diverse applications.
  • Recent Achievements: Successful implantation of silicon nitride spinal implants in multiple countries.
  • Current Projects: Expansion into technical and antipathogenic ceramic solutions.
  • Partnerships: Collaborations with healthcare providers and research institutions globally.
  • Financial Condition: Continuously innovating to maintain a strong market presence and financial stability.

Stay updated with the latest news from SINTX Technologies, as they continue to push the boundaries of advanced ceramics and medical innovation.

News

SINTX TECHNOLOGIES ENTERS INTO A SECOND LONG TERM SUPPLY AGREEMENT FOR THE AEROSPACE MARKET

Rhea-AI Summary
SINTX Technologies, Inc. announces a 10-year Long-Term Agreement with a leading aerospace manufacturer, valued at up to $8 million. The agreement focuses on manufacturing ceramic aircraft engine components, expanding SINTX's reach beyond the biomedical sector. SINTX's Quality Management System is certified for aerospace and biomedical sectors, showcasing their expertise and capabilities.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.35%
Tags
none
-
News

SINTX Technologies Announces Closing of $4.0 Million Public Offering

Rhea-AI Summary
SINTX Technologies, Inc. (SINT) has closed a public offering of 16,000,000 units, each consisting of one share of common stock and various warrants, at a public offering price of $0.25 per unit. The gross proceeds are approximately $4.0 million. The offering was made pursuant to a registration statement on Form S-1, declared effective by the SEC on January 31, 2024. Maxim Group LLC acted as sole placement agent, and Ascendiant Capital Markets LLC acted as the Company’s financial advisor.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.33%
Tags
offering
-
News

SINTX Technologies Announces Pricing of $4.0 Million Public Offering

Rhea-AI Summary
SINTX Technologies, Inc. (SINT) announced a public offering of 16,000,000 units, each consisting of one share of common stock, a pre-funded warrant, and two types of warrants, with gross proceeds expected to be approximately $4.0 million. The offering is expected to close on February 2, 2024, and is being made pursuant to a registration statement declared effective by the SEC on January 31, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-34.47%
Tags
offering
News

SINTX SUBSIDIARY TECHNOLOGY ASSESSMENT & TRANSFER TO DEVELOP 3D PRINTING AND CMCs WITH DEVCOM-ARMY RESEARCH LABORATORY

Rhea-AI Summary
SINTX Technologies, Inc. (NASDAQ: SINT) announced a Cooperative Research and Development Agreement (CRADA) with the U.S. Army Combat Capabilities Development Command Army Research Laboratory (DEVCOM ARL) to collaborate on ceramic additive manufacturing and ceramic matrix composites. This partnership is expected to leverage the strengths of both organizations in developing advanced technologies for hypersonic vehicle applications and other high-temperature materials.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-34.47%
Tags
none
-
News

SINTX TECHNOLOGIES SHARES SELECT PRELIMINARY Q4 2023 AND FULL YEAR 2023 REVENUE UPDATE

Rhea-AI Summary
SINTX Technologies, Inc. reported estimated unaudited revenues of approximately $902k in Q4 2023 and $2.6 million for the year ended December 31, 2023. This represents an 18% increase in Q4 2023 revenue versus Q4 2022, and a 68% increase in 2023 revenue compared to 2022. The 2023 revenue figures reflect a 333% increase in revenues for the year that ended December 31, 2021. Commercial revenues of $582K in Q4 2023 and $1.2 million for the full year 2023 were achieved primarily by the sale of products in the aerospace, biomedical, and energy markets. Government contracts in these markets made up $320K in Q4 and $1.4 million for the full year. SINTX anticipates continued revenue growth in 2024 driven primarily by new commercial product adoption, innovative technology development, and government contract opportunities.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.97%
Tags
earnings
-
News

SINTX TECHNOLOGIES SIGNIFICANTLY STRENGTHENS ITS ANTIPATHOGENIC PATENT PORTFOLIO

Rhea-AI Summary
SINTX Technologies, Inc. (SINT) has been granted its sixth United States patent in the last year, all related to the antipathogenic properties of silicon nitride. The significance of the patents lies in their innovative approaches towards utilizing silicon nitride in a wide range of antipathogenic solutions, covering applications in agriculture, dentistry, medical implants, durable medical equipment, and personal protective equipment.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.28%
Tags
none
News

SINTX TECHNOLOGIES ENTERS A LONG-TERM SUPPLY AGREEMENT FOR AEROSPACE COMPONENTS

Rhea-AI Summary
SINTX Technologies, Inc. has entered a Long-Term Agreement to supply jet engine components made of its silicon nitride, expanding its capabilities beyond biomedical implants. The agreement has no minimum requirements and is projected to generate annual revenues of less than $0.25 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.5%
Tags
none
-
News

SINTX Technologies Awarded Phase II NIH Grant for Silicon Nitride-PEEK 3D Printed Composite Spinal Implants

Rhea-AI Summary
SINTX Technologies has been awarded a Phase II grant of $1,972,826 by the NIH to develop a 3D printed composite spinal implant. The grant represents a critical milestone in expanding the antibacterial and osseointegrative properties of silicon nitride into composite structures.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.84%
Tags
clinical trial
-
News

3DCERAM SINTO INC. and SINTX TECHNOLOGIES ANNOUNCE COLLABORATION TO DEVELOP MATERIALS AND TECHNOLOGIES FOR ADDITIVE MANUFACTURING OF ADVANCED CERAMICS

Rhea-AI Summary
3DCERAM Sinto, Inc. and SINTX Technologies, Inc. announced a collaboration to develop novel resins and processes for additive manufacturing of ceramic products. The collaboration aims to produce high-value resins, 3D print ceramic components, and subject them to advanced thermal processing, primarily for the biomedical and investment casting industries.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.24%
Tags
none
News

SINTX TECHNOLOGIES ANNOUNCES ITS NEW UTAH ARMOR FACILITY IS FULLY OPERATIONAL

Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.81%
Tags
none

FAQ

What does SINTX Technologies, Inc. specialize in?

SINTX Technologies specializes in advanced ceramics and medical-grade silicon nitride, used primarily in spinal fusion and various medical applications.

What are the key features of SINTX's silicon nitride products?

SINTX's silicon nitride products feature a unique nanosurface texture that promotes bone growth, provides excellent imaging capabilities, and has antibacterial properties.

Where have SINTX's spinal implants been successfully implanted?

SINTX's silicon nitride spinal implants have been successfully implanted in patients in the US, Europe, Brazil, and Taiwan.

Is SINTX Technologies FDA registered?

Yes, SINTX Technologies operates the only FDA-registered and ISO 13485 certified silicon nitride medical device manufacturing facility in the world.

What other applications is SINTX involved in?

Apart from medical devices, SINTX is also engaged in developing advanced ceramic solutions for technical and antipathogenic applications.

How does SINTX's silicon nitride benefit medical applications?

SINTX's silicon nitride promotes bone growth, offers clear imaging capabilities, and has antibacterial properties, making it ideal for medical applications.

What are the recent achievements of SINTX Technologies?

Recent achievements include the successful implantation of silicon nitride spinal implants in multiple countries and expansion into new advanced ceramic applications.

Who can benefit from SINTX's products?

Both patients and surgeons can benefit from SINTX's advanced silicon nitride medical devices, which are designed to improve the quality of life and surgical outcomes.

How does SINTX contribute to healthcare innovation?

SINTX contributes to healthcare innovation by developing advanced biomaterials like silicon nitride that enhance patient outcomes and offer new solutions in medical technology.

Where can I find the latest news about SINTX Technologies?

You can find the latest news and updates about SINTX Technologies on their official website's news section at www.sintx.com/news.

Stock SINT logo
Sintx Technologies, Inc.

Nasdaq:SINT

SINT Rankings

N/A Ranked by Market Cap
N/A Ranked by Dividends

SINT Stock Data

3.97M
750.00k
3.67%
1.64%
7.14%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
SALT LAKE CITY